| __timestamp | Intra-Cellular Therapies, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 5280000 |
| Thursday, January 1, 2015 | 87718074 | 7148000 |
| Friday, January 1, 2016 | 93831530 | 19594000 |
| Sunday, January 1, 2017 | 79419009 | 22894000 |
| Monday, January 1, 2018 | 132166913 | 50337000 |
| Tuesday, January 1, 2019 | 89124838 | 109450000 |
| Wednesday, January 1, 2020 | 65782137 | 90450000 |
| Friday, January 1, 2021 | 88845513 | 104128000 |
| Saturday, January 1, 2022 | 134715000 | 108630000 |
| Sunday, January 1, 2023 | 180142000 | 134951000 |
In pursuit of knowledge
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Rhythm Pharmaceuticals, Inc. have been at the forefront of this race.
Since 2014, Intra-Cellular Therapies has consistently increased its R&D investment, peaking in 2023 with a staggering 750% increase from its 2014 levels. This growth underscores their dedication to pioneering treatments in the mental health sector.
Rhythm Pharmaceuticals has also shown a robust commitment, with R&D spending surging by over 2,500% from 2014 to 2023. Their focus on rare genetic disorders has driven this substantial investment.
Both companies exemplify the relentless pursuit of innovation, with their R&D strategies reflecting broader industry trends towards personalized medicine and advanced therapeutics.
Research and Development Expenses Breakdown: Novartis AG vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.